Abstract
BACKGROUND AND PURPOSE: The cavum septum pellucidum, a cavity filled with CSF, is localized between the 2 lateral ventricles of the brain. The cavum is present in all neonates, but it typically closes within 5 months after birth. In some cases, this closure does not occur and a persistent or enlarged cavum septum pellucidum has been linked, in some studies, to psychiatric disorders. However, the clinical relevance in the general population is unknown. In this study, we examined the relationship between the cavum septum pellucidum and volumes of brain structures, cognitive function, and emotional and behavioral problems in children.
MATERIALS AND METHODS: This study was embedded in the Generation R Study, a prospective cohort in Rotterdam, the Netherlands. MR imaging studies of 1070 children, 6–10 years of age, were systematically evaluated for the presence and length of a persistent cavum septum pellucidum. An enlarged cavum septum pellucidum was defined as a cavum length of ≥6 mm. Groups without, with persistent, and with enlarged cavum septi pellucidi were compared for brain structure volumes, nonverbal intelligence, and emotional and behavioral problems.
RESULTS: The prevalence of cavum septi pellucidi in our sample was 4.6%. Children with an enlarged cavum septum pellucidum had a larger corpus callosum, greater thalamic and total white matter–to–total brain volume ratio, and smaller lateral ventricle volumes. We did not find a relationship between cavum septi pellucidi and cognitive function or emotional and behavioral problems.
CONCLUSIONS: The cavum septum pellucidum is a normal structural brain variation without clinical implications in this population-based sample of school-aged children.
ABBREVIATIONS:
- CBCL
- Child Behavior Checklist
- CSP
- cavum septum pellucidum
- IQ
- intelligence quotient
- M
- marginal mean
- ρs
- Spearman partial correlation
- SE
- standard error
The septum pellucidum is a thin plate consisting of 2 fused laminae or septa located between the lateral ventricles of the brain. At birth, these 2 septa are separated and form the lateral walls of a cavity filled with CSF, the cavum septum pellucidum (CSP). The 2 septa of the cavum typically fuse into a single septum pellucidum within 5 months after birth, likely due to growth of the surrounding brain structures.1⇓–3 However, in some cases, the septa do not fuse and form the persistent cavum. A persistent CSP with a cavum length of <5 mm is common in a large proportion of healthy subjects, with prevalence rates of up to 30% in the adult population,1,4 and is therefore considered a normal variant. In general, the size of a normal-variant septum is estimated at approximately 1–4 mm.1,5 There is no clear cutoff value to define enlargement of the CSP, but many previous studies used a common cutoff of ≥6 mm.2,3,5⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–16
In patients with schizophrenia and an enlarged CSP, smaller amygdala volumes and smaller left posterior parahippocampal gyrus volumes compared with patients without CSP were found.12 Other studies did not find a relation to global or specific brain structure volumes.7,9,13,17 However, because the postnatal closure of the CSP is presumed to be dependent on growing brain structures,2,3 we would expect the brain regions in direct or close contact with the septum pellucidum to be smaller in subjects with enlarged CSPs.
Because an enlarged CSP is considered a neurodevelopmental anomaly, it has been postulated as a potential marker for psychiatric disorders that have neurodevelopmental origins. Indeed, an enlarged CSP has been evaluated in a broad range of psychiatric adult populations, typically by measuring the anterior-to-posterior CSP length on MR imaging studies, but with mixed results. Some studies have shown significantly higher rates of enlarged CSPs in adult patients with schizophrenia,5,9,18 schizophrenia spectrum disorder,18 bipolar disorder,11 and disruptive behavior disorder19 and opiate-dependent subjects.16 However, other studies did not find higher rates of enlarged CSPs in schizophrenia,2,6,10,12,20 bipolar disorder,21 and other psychiatric disorders, including attention deficit/hyperactivity disorder,22 borderline personality disorder,13 depression,13 or obsessive-compulsive disorder.14
The relationship between CSP and cognition is even less clear. Nopoulos et al23 found a negative correlation between cavum length and the intelligence quotient (IQ) in patients with schizophrenia and an enlarged CSP; however, they did not show this relationship between an enlarged CSP and cognition in the control group. On the other hand, another study has found that a larger proportion of subjects evaluated for mental retardation also had an enlarged CSP.24 In addition, an enlarged CSP has been found in children with syndromes that include cognitive impairments such as fetal alcohol syndrome25 or Apert syndrome.26 These studies may suggest that a relationship exists between an enlarged CSP and cognitive function that extends to the general population.
The heterogeneity in different cutoffs used to define the presence of an enlarged CSP could contribute to some of the mixed findings. The presence of an enlarged CSP, according to the ≥6-mm cutoff varied from 0% to 19.5% in patients and from 0% to 14.7% in controls.2,3,6⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 Because control groups for clinical studies do not always reflect the general population, the prevalence of an enlarged CSP in the general pediatric population is unknown. Thus, the goal of this study was to determine the prevalence of a CSP in the general pediatric population and to examine the relationship between the size of a CSP and brain structure volumes, nonverbal intelligence (as a proxy for cognitive function), and emotional or behavioral problems in children.
Given the previously reported link between an enlarged CSP and behavioral or emotional disorders,11,15,19 we hypothesized that a relationship between the size of a CSP and behavioral problems and cognitive performance would be present in a population-based sample of children.
Materials and Methods
Participants
The current study was embedded in the longitudinal population-based Generation R Study. An overview of the Generation R Study design is published elsewhere.27,28 Briefly, the Generation R Study is a prospective birth cohort study that started in Rotterdam between 2002 and 2006. After informed consent was obtained, a total of 9778 pregnant women were included. Information on the demographic characteristics included educational levels of the mother. Multiple measurements were collected during pregnancy (eg, maternal alcohol use and smoking behavior).29 A neuroimaging substudy of children 6–9 years of age was initiated in 2009 and involved 1070 children.28 Exclusion criteria were general contraindications for MR imaging examination (ie, pacemaker, ferrous metal implants), severe motor or sensory disorders (deafness or blindness), neurologic disorders (ie, seizures or tuberous sclerosis), moderate-to-severe head injuries with loss of consciousness, and claustrophobia. Informed consent was obtained from the parents before participation. The study was approved by the Medical Ethics Committee at the Erasmus Medical Center-Sophia, Rotterdam.28
MR Imaging Acquisition
Children were familiarized with the MR imaging scanners using a mock scanning procedure.28 MR images were acquired on a 3T scanner (Discovery MR750; GE Healthcare, Milwaukee, Wisconsin) using an 8-channel head coil for signal reception. Following a 3-plane localizing and coil-intensity calibration scan, a high-resolution T1-weighted inversion recovery fast-spoiled gradient-recalled sequence was obtained with the following parameters: TR = 10.3 ms, TE = 4.2 ms, TI = 350 ms, NEX = 1, flip angle = 16°, readout bandwidth = 20.8 kHz, matrix = 256 × 256. The total scan time for the T1 was 5 minutes 40 seconds.28 The MR images underwent a 6-parameter affine transformation into a study-specific template at 1 × 1 × 1 mm isotropic resolution.30
CSP Assessment
The CSP was assessed in a standardized manner by a single trained neuroradiologist, blinded to subject information. Anatomic boundaries for the CSP were as follows: the genu of the corpus callosum defined the anterior boundary, the body of the corpus callosum defined the superior boundary, the rostrum of the corpus callosum and the anterior commissure defined the inferior boundary, and the anterior limb and pillars of the fornix defined the posterior boundary. On-line Fig 1 illustrates the anterior and posterior boundaries of the CSP in the sagittal plane. Similar to other studies,5⇓⇓⇓–9,12,13,15,19,20,22,23 the anterior-to-posterior length of the CSP was measured by counting the number of coronal 1-mm slices on which a cavum was visible. A cavum was labeled as enlarged when its length was ≥6 slices (ie, ≥6 mm).2,3,6⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 Absence of a CSP was labeled “no CSP.” A cavum of <6 mm in length was categorized as a normal-variant CSP. Figure 1 illustrates the presence of an enlarged CSP. Intrarater reliability was based on 50 repeat ratings and was found to be high (test-retest reliability, Cronbach α = 0.96). Scans that were of insufficient quality to determine the existence or length of a CSP were excluded from the analyses (12.5%, n = 134). The insufficient scan quality was mainly due to movement artifacts, which are a well-known problem when performing MR imaging studies in unsedated children at a young age.
Global and Regional Brain Structures
Volumes of global and regional brain structures were measured using FreeSurfer image analysis, Suite 5.1 (http://surfer.nmr.mgh.harvard.edu/). The technical details of these procedures have been described elsewhere.31,32 Briefly, this process included intensity normalization, the removal of nonbrain tissue, automated Talairach transformation into standard space, and segmentation of the cortical and subcortical white and gray matter volumetric structures. The volumes of brain regions in close vicinity to the CSP were selected for analysis. These regions included the corpus callosum, lateral ventricles, thalamus, hippocampus, amygdala, and the caudate nucleus. Volumes of global brain measures were also examined, including total brain, total gray matter, and total white matter volumes.
Emotional and Behavioral Problems
Emotional and behavioral problems were measured using the sum scores of the 99 items of the Child Behavior Checklist (CBCL).33 This questionnaire, completed by the parents when the children were approximately 6 years of age, includes behavioral, emotional, and social problems in school-aged children. The items were calculated for several syndrome scales: emotionally reactive, anxious/depressed, somatic complaints, withdrawn, attention problems, and aggressive behavior. Broadband scores of internalizing symptoms and externalizing symptoms were used.
Nonverbal Intelligence
The Generation R cohort includes children from different ethnic minorities with differences in Dutch language abilities. Therefore, nonverbal intelligence was measured using 2 subtests of the Snijders-Oomen Nonverbal Intelligence Test 2.5–7-Revised.34 Due to time constraints, we selected 2 subtests: Mosaics and categories for testing spatial insight and abstract reasoning abilities, respectively. Because the correlation between the sum of these 2 subtests and the full SON-R IQ battery is very high (r = 0.86), these subdomain scores can be used as nonverbal IQ scores.35 Raw subtest scores were transformed according to population- and age-specific norms with a mean value of 100 ± 15.36 Handedness was determined using the Edinburgh Handedness Inventory.29
Statistical Analyses
Demographic differences between the no/normal-variant CSP (control group) and the enlarged CSP group were analyzed using a χ2 test for categoric variables (sex, ethnicity, handedness, maternal education, maternal alcohol use during pregnancy, maternal smoking behavior during pregnancy) and independent t tests for continuous variables (age). Differences in brain structure volumes, nonverbal intelligence, and emotional and behavioral problems between the controls and the enlarged CSP group were tested using ANCOVAs. Covariates were added to the model if they resulted in a >5% change in the effect estimate, including the child's age, sex, ethnicity, and maternal education. The analyses of regional brain structure volumes were also adjusted for total problem score and total brain volume. Because the control group did include a small CSP (0–5 mm) and the biologic relevance of a normal-sized CSP is not clear, 2 additional sensitivity analyses were performed for brain structure volumes, nonverbal intelligence, and emotional and behavior problems. First, sensitivity analyses were performed comparing the 2 extreme categories (0 versus ≥6 mm), and second, an analysis was performed using a classification into 3 groups (0 versus 1–5 versus ≥6 mm). For certain analyses of brain structure volumes and emotional or behavioral scores, the length of the CSP was used as a continuous variable.
All analyses were performed using the Statistical Package for the Social Sciences, Version 21.0 (SPSS; IBM, Armonk, New York). In addition, a nonparametric analysis with CSP length as a continuous variable was performed using Statistical Analysis Software, Version 9.3 (SAS Institute, Cary, North Carolina). To correct for multiple testing, we calculated the effective number of tests on the basis of the covariance structure among the different outcomes.37 We found the number of effective tests to be 5; thus, the corrected threshold for significance was P < .01. Data were missing on internalizing symptoms (10.5% missing data), externalizing symptoms (10.0%), nonverbal IQ (8.8%), and the covariates, maternal education (9.5%) and the CBCL sum score (9.5%). Missing values were estimated using a multiple imputation method with 5 imputations and 10 iterations. Finally, an additional nonresponse analysis was performed comparing the baseline characteristics of the study participants with the group of children excluded due to insufficient scan quality.
Results
Sample Characteristics
Sample characteristics are presented in Table 1. Children in the control group and the enlarged CSP group did not differ in age at scanning [t(934) = 0.26, P = .79)], sex [χ2(1) = 0.03, P = .86], ethnicity [χ2(2) = 2.68, P = .26], handedness [χ2(1) = 0.001, P = .98], maternal education [χ2(2) = 0.93, P = .63], maternal alcohol use during pregnancy [χ2(3) = 1.53, P = .68], and maternal smoking behavior during pregnancy [χ2(2) = 0.23, P = .89].
CSP
Figure 2 shows the distribution of the anterior-to-posterior cavum lengths in the entire sample. The prevalence of a CSP in the study population was 64.9%, categorized into normal-variant CSP (60.3% of total study population) and enlarged CSP (4.6% of total study population). The mean cavum length in the control group was 2.67 mm; lengths ranged from 1 to 5 mm. The mean cavum length in the enlarged CSP group was 12.56 mm; lengths in this group ranged from 6 to 37 mm. A histogram of CSP lengths in the enlarged CSP group is shown in On-line Fig 2.
Global Brain Structures
Table 2 shows the differences in global structure volumes between the controls and the enlarged CSP group. Children in the enlarged CSP group had larger total brain volumes [F(1,93) = 3.93, P = 0.05, partial η2 = 0.004] and larger total white matter/total brain ratio volumes [F(1,93) = 6.81, P = .009, partial η2 = 0.007] compared with the children in the control group, adjusting for the covariates. After correcting for multiple testing, only the difference in white matter/total brain ratio volume remained. Comparing the children in the controls (n = 893) with the those in the enlarged CSP group (n = 43) or comparison of the 3 groups (0 versus 1–5 versus ≥6 mm) showed similar results. CSP length was positively correlated with total brain volume (Spearman partial correlation, ρs = 0.19, P < .001) and white matter/total brain ratio volume (Spearman partial correlation, ρs = 0.13, P < .001).
Regional Brain Structures
Table 3 shows the difference in volumes of specific structures between the controls and the enlarged CSP group. Children in the enlarged CSP group had larger corpus callosum volumes [F(1,93) = 6.79, P = .009, partial η2 = 0.007], larger thalamus volumes [F(1,93) = 11.21, P = .001, partial η2 = 0.012], and smaller amygdala volumes [F(1,93) = 4.48, P = 0.04, partial η2 = 0.005] compared with the children in the control group, after controlling for covariates. After we corrected for multiple testing, only differences in the corpus callosum and thalamus volumes remained. On-line Table 1 presents the results of the comparison of children in the no-CSP group (n = 329) with the those in the enlarged CSP group (≥6 mm). Additionally, children with an enlarged CSP had smaller lateral ventricle volumes compared with children with complete absence of a cavum [F(1,36) = 8.16, P = .005, partial η2 = 0.022]. On-line Table 2 presents the results of the comparison of the 3 groups (0 versus 1–5 versus ≥6 mm). In this analysis, the difference in amygdala volume disappeared, and the 3 groups were found to differ in caudate nucleus volume [F(2,93) = 5.33, P = .005, partial η2 = 0.011]. CSP length was positively correlated with the volume of the corpus callosum (Spearman partial correlation, ρs = 0.12, P < .001), thalamus (Spearman partial correlation, ρs = 0.08, P = .02), and caudate nucleus (Spearman partial correlation, ρs = −.10, P = .002) and was negatively correlated with lateral ventricle volumes (Spearman partial correlation, ρs = −.20, P < .001).
Nonverbal Intelligence
Children in the no/normal-sized CSP and the enlarged CSP groups did not differ in nonverbal IQ scores [F(1,93) = 0.05, P = 0.82, partial η2 = 0.000]. Estimated marginal means (M) for nonverbal IQ were M = 101.63, standard error (SE) = 0.46 versus M = 101.13, SE = 2.08. The results of comparing the children in the no-CSP group (n = 329) with the enlarged CSP group (n = 43) were also not significant. Comparing 3 groups (0 versus 1–5 versus ≥6 mm) did show a difference in nonverbal IQ scores [F(1,93) = 3.37, P = 0.04, partial η2 = 0.007]. Estimated marginal means for the 3 groups were M = 100.08, SE = 0.75 versus M = 102.53, SE = 0.57 versus M = 101.14, SE = 2.07; however, this finding did not survive correction for multiple testing. A nonparametric test with CSP length as a continuous variable did not show a correlation between CSP length and nonverbal IQ scores.
Emotional or Behavioral Problems
Children in the control group and the enlarged CSP group did not differ in emotional [F(1,93) = 2.35, P = 0.13, partial η2 = 0.003] or behavioral [F(1,93) = 0.35, P = 0.55, partial η2 = 0.000] problem scores. Estimated marginal means for emotional scores were M = 2.48, SE = 0.04 versus M = 2.18, SE = 0.19. Estimated marginal means for behavioral scores were M = 2.80, SE = 0.04 versus M = 2.93, SE = 0.20. Mean scores are reported as square-root-transformed scores. Comparing the children in the no-CSP group (n = 329) with those in the enlarged CSP group (n = 43) or comparing 3 groups (0 mm 1–5 versus ≥6 mm) did not change the results. A Spearman correlation coefficient test with CSP length as a continuous variable also did not show a correlation between CSP length and emotional or behavioral scores.
Participant versus Excluded Analysis
Of all 1070 scans, 134 scans (12.5%) were of insufficient quality and were excluded from the analyses. Children whose scans were excluded did not differ from the current study sample (n = 936) in age at the time of scanning [t(1068) = −0.81, P = .42], sex [χ2(1) = 3.18, P = .07], ethnicity [χ2(2) = 3.85, P = .15], handedness [χ2(1) = 0.43, P = .51], nonverbal IQ [t(980) = −0.59, P = .56], maternal education [χ2(2) = 3.83, P = .15], maternal alcohol use during pregnancy [χ2(3) = 1.12, P = .77], and maternal smoking behavior during pregnancy [χ2(2) = 5.64, P = .06]. However, children excluded from the analyses had higher CBCL sum scores than the included children [t(970) = 2.53, P = .01].
Discussion
To further understand the brain structural correlates associated with an enlarged CSP, we evaluated the relationship between the CSP and the volume of global and regional brain structures. Children with enlarged CSPs were found to have larger total white matter/total brain volume ratios and corpus callosum and thalamus volumes. Similar to studies in patients with schizophrenia spectrum disorder,12 amygdala volumes were smaller in subjects with enlarged CSPs. However, this result did not remain significant after correction for multiple testing. In addition, children with enlarged CSPs had smaller lateral ventricle volumes compared with children with a total absence of a cavum. CSP length was positively correlated with total brain volume; white matter/total brain ratio; and corpus callosum, thalamus, and caudate nucleus volumes. CSP length was negatively correlated with lateral ventricle volumes.
It has been postulated that the postnatal closure of the CSP is a result of growth of surrounding brain structures, exerting pressure on the 2 leaflets of the septum pellucidum and thereby facilitating fusion.2,3 Brain development in this early postnatal period has not been extensively studied, but a recent study on infant brain development in the first 3 months after birth38 presents growth rates for several ROIs of the current study. The lateral ventricles were found to grow at the highest rate, increasing around 78% in the first 90 days after birth. As hypothesized, the rapid growth of the lateral ventricles in these first months after birth could induce closure of the cavum by exerting lateral pressure on both sides of the septal leaves. We speculated that smaller growth rates in this period could cause failure of CSP closure. If these early growth rates are decisive for structure volumes at a later age, our results support this hypothesis because the lateral ventricles were smaller in children with the presence of a CSP compared with those with total absence of a cavum. Previous studies have reported an association between an enlarged CSP and syndromes including cognitive impairment such as fetal alcohol syndrome and Apert syndrome.25,26
Mechanical factors that potentially play a role in the closure of the CSP in the general pediatric population could also extend to these clinical conditions. In these syndromes, there is an obvious change in brain volume and/or head size, which could cause major changes in the exerting pressure on the septal leaves, leading to a failure of CSP closure. The enlarged CSP would rather be a consequence of the anatomic and structural abnormalities in these syndromes than a marker of cognitive function itself. In addition, the larger total amount of white matter (larger total white matter/total brain volumes ratios) in the enlarged CSP group could also contribute to a change in mechanical factors that cause the lateral ventricles to grow less rapidly in the early postnatal period. This, in turn, could modify the exerting lateral pressure on both sides of the septal leaves and alter the possible closure mechanisms of the septal leaves.
In addition, other regional brain structures were also found to be larger in children with a persistent CSP. For example, the corpus callosum is a structure that directly surrounds the CSP but was found to be larger in children with an enlarged CSP. We speculated that the exertion of lateral pressure, like the pressure of growing lateral ventricles, is more effective in facilitating the postnatal fusing process of the septum leaves if the corpus callosum is smaller. Thus, under the rubric of a mechanical closure hypothesis of the CSP, larger brain structures would require greater distributed pressure along the structure to close the septum. However, because we do not have MR imaging data available during the early postnatal period, it is not possible to draw conclusions concerning the timing and longitudinal relationship with neighboring structures related to the postnatal closure of the CSP. It is likely that multiple-yet-unknown factors play a role in this process.
Furthermore, it would be interesting to search for genetic factors that play a role in the closure of the CSP. Because the Generation R Study is currently starting to prospectively scan the parents of a subgroup of children scanned in this study, assessment of the presence and size of a CSP in the parents could be of great value to demonstrate the influence of genetics. This may well be a focus of further studies.
The prevalence of an enlarged CSP in our population-based sample of school-aged children is 4.6%. This falls within the range described in prior literature in adult populations.2,3,5⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 While earlier research tended to focus on psychiatric populations, the prevalence in healthy control groups in these studies varied substantially from 0% to 14.7%. Because many of these studies had small sample sizes and control groups are not always reflective of recruitment from the general population, we believe that our study provides more accurate rates of enlarged CSPs in the general pediatric population. However, we are unaware of studies assessing changes with time in the size or presence of the CSP; thus, longitudinal studies are necessary to address this question.
An enlarged CSP is considered a potential marker for neurodevelopmental abnormalities. However, in contrast to earlier studies,11,15,19 we did not find a relationship between an enlarged CSP and nonverbal intelligence. We also did not find a relationship between emotional or behavioral problems and an enlarged CSP. While we found no evidence for behavioral correlates of an enlarged CSP in this population-based sample of school-aged children, some neuropsychiatric disorders that show a relationship with an enlarged CSP have a typical age of onset in late adolescence and early adulthood. For example, schizophrenia spectrum disorders and bipolar disorders generally present with the first symptoms between 17 and 25 years of age.7,21 Thus, it is possible that the relationship between an enlarged CSP and psychopathology will emerge later, parallel to the emergence of psychiatric symptoms. The small, nonsignificant, volumetric differences of certain brain structures found in this study could theoretically indicate some structural changes in brain regions that might form the basis for these diseases.
There are some limitations in the study protocol. Only 1 rater evaluated the MR imaging studies and assessed the presence and size of the CSP. However, the rater was specifically trained to evaluate the CSP and performed all the measurements in a standardized manner. Furthermore, 1 exclusion criterion to undergo MR imaging examination in the Generation R Study design is a history of moderate-to-severe head injuries with loss of consciousness. In previous literature, a possible relationship between an enlarged CSP and traumatic brain injury has been reported in adults as well as in children.39,40 Therefore, exclusion of children with previous moderate-to-severe brain injury potentially resulted in selection bias. In addition, missing values on internalizing and externalizing symptoms, nonverbal IQ, and certain covariates are a potential limitation of the study design, but we applied multiple imputation methods to reduce the potential bias introduced as a result of missing data to a minimum.
The strengths of the current study are the standardized MR imaging measurements obtained in a large population-based sample of 1070 children of different ethnicities and backgrounds. The study contains an extensive data collection with a broad range of physiologic and environmental measures. Therefore, it includes valuable data representative of the pediatric population in general.
Conclusions
The CSP is a structural brain variation without cognitive or behavioral implications in this population-based sample of school-aged children. However, we did find a relationship between CSP and global and regional volumetric brain measures, but the clinical relevance of this relationship is as yet uncertain.
Footnotes
Marjolein H.G. Dremmen and Roos H. Bouhuis contributed equally to this work.
Disclosures: Marjolein H.G. Dremmen—RELATED: Grant: the Netherlands Organization for Health Research and Development*; UNRELATED: Employment: Pediatric Radiologist at Erasmus Medical Center, Rotterdam. Roos H. Bouhuis—RELATED: Grant: the Netherlands Organization for Health Research and Development.* Hanan El Marroun—RELATED: Grant: European Union, Comments: The Horizon 2020 research and innovation program (grant agreement No.633595 DynaHEALTH and No.733206 LifeCycle) of the European Union.* Frank C. Verhulst—UNRELATED: Royalties: distributor of the Dutch translations of the Achenbach System of Empirically Based Assessment, from which I receive remuneration. Tonya White—RELATED: Grant: the Netherlands Organization for Health Research and Development.* *Money paid to the institution.
This study was financially supported through Netherlands Organization for Health Research and Development TOP project No. 91211021. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; the Netherlands Organization for Health Research and Development; and the Netherlands Organization for Scientific Research, the Ministry of Health, Welfare and Sport.
Indicates open access to non-subscribers at www.ajnr.org
REFERENCES
- Received August 29, 2018.
- Accepted after revision December 1, 2018.
- © 2019 by American Journal of Neuroradiology